MedTrace Logo

Bergamot and Cardio-Metabolic Risk Factors

NCT02205567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2015-08-06

No results posted yet for this study

Summary

Bergamot-derived products have shown significant effects on plasma lipids. We aim in the present study to evaluate the effect of bergamot on several cardio-metabolic risk markers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Bergamot-derived product

Group 1: 500mg/day Group 2: 1000mg/day

Sponsors & Collaborators

  • University of Palermo

    lead OTHER

Principal Investigators

  • Giuseppe Montalto, MD · University of Palermo, Italy

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-06-30
Completion
2015-08-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02205567 on ClinicalTrials.gov